Hybrid Bone Substitute Containing Tricalcium Phosphate and Silver Modified Hydroxyapatite-Methylcellulose Granules

Overview

Journal J Funct Biomater

Specialty Biomedical Engineering

Date 2024 Jul 26

PMID 39057317

Authors

Joanna P Czechowska

Annett Dorner-Reisel

Aneta Zima

Affiliations

Soon will be listed here.

Abstract

Despite years of extensive research, achieving the optimal properties for calcium phosphate-based biomaterials remains an ongoing challenge. Recently, 'biomicroconcretes' systems consisting of setting-phase-forming bone cement matrix and aggregates (granules/microspheres) have been developed and studied. However, further investigations are necessary to clarify the complex interplay between the synthesis, structure, and properties of these materials. This article focusses on the development and potential applications of hybrid biomaterials based on alpha-tricalcium phosphate (αTCP), hydroxyapatite (HA) and methylcellulose (MC) modified with silver (0.1 wt.% or 1.0 wt.%). The study presents the synthesis and characterization of silver-modified hybrid granules and seeks to determine the possibility and efficiency of incorporating these hybrid granules into αTCP-based biomicroconcretes. The αTCP and hydroxyapatite provide structural integrity and osteoconductivity, the presence of silver imparts antimicrobial properties, and MC allows for the self-assembling of granules. This combination creates an ideal environment for bone regeneration, while it potentially may prevent bacterial colonization and infection. The material's chemical and phase composition, setting times, compressive strength, microstructure, chemical stability, and bioactive potential in simulated body fluid are systematically investigated. The results of the setting time measurements showed that both the size and the composition of granules (especially the hybrid nature) have an impact on the setting process of biomicroconcretes. The addition of silver resulted in prolonged setting times compared to the unmodified materials. Developed biomicroconcretes, despite exhibiting lower compressive strength compared to traditional calcium phosphate cements, fall within the range of human cancellous bone and demonstrate chemical stability and bioactive potential, indicating their suitability for bone substitution and regeneration. Further in vitro studies and in vivo assessments are needed to check the potential of these biomaterials in clinical applications.

References

Zuo Y, Yang F, Wolke J, Li Y, Jansen J . Incorporation of biodegradable electrospun fibers into calcium phosphate cement for bone regeneration. Acta Biomater. 2009; 6(4):1238-47. DOI: 10.1016/j.actbio.2009.10.036. View

Chen L, Doyle P . Design and Use of a Thermogelling Methylcellulose Nanoemulsion to Formulate Nanocrystalline Oral Dosage Forms. Adv Mater. 2021; 33(29):e2008618. DOI: 10.1002/adma.202008618. View

Nunes M, de Souza Maguerroski Castilho M, Veeck A, da Rosa C, Noronha C, Maciel M . Antioxidant and antimicrobial methylcellulose films containing Lippia alba extract and silver nanoparticles. Carbohydr Polym. 2018; 192:37-43. DOI: 10.1016/j.carbpol.2018.03.014. View

Meng D, Dong L, Wen Y, Xie Q . Effects of adding resorbable chitosan microspheres to calcium phosphate cements for bone regeneration. Mater Sci Eng C Mater Biol Appl. 2014; 47:266-72. DOI: 10.1016/j.msec.2014.11.049. View

Pina S, Olhero S, Gheduzzi S, Miles A, Ferreira J . Influence of setting liquid composition and liquid-to-powder ratio on properties of a Mg-substituted calcium phosphate cement. Acta Biomater. 2009; 5(4):1233-40. DOI: 10.1016/j.actbio.2008.11.026. View

Fernandez E, Gil F, Ginebra M, Driessens F, Planell J, Best S . Calcium phosphate bone cements for clinical applications. Part I: solution chemistry. J Mater Sci Mater Med. 2004; 10(3):169-76. DOI: 10.1023/a:1008937507714. View

Nuzulia N, Mart T, Ahmed I, Sari Y . The Use of Microspheres for Cancer Embolization Therapy: Recent Advancements and Prospective. ACS Biomater Sci Eng. 2024; 10(2):637-656. DOI: 10.1021/acsbiomaterials.3c00659. View

Demir-Oguz O, Boccaccini A, Loca D . Injectable bone cements: What benefits the combination of calcium phosphates and bioactive glasses could bring?. Bioact Mater. 2022; 19:217-236. PMC: 9048153. DOI: 10.1016/j.bioactmat.2022.04.007. View

Lansdown A . A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices. Adv Pharmacol Sci. 2010; 2010:910686. PMC: 3003978. DOI: 10.1155/2010/910686. View

10.

Zima A, Czechowska J, Siek D, Olkowski R, Noga M, Lewandowska-Szumiel M . How calcite and modified hydroxyapatite influence physicochemical properties and cytocompatibility of alpha-TCP based bone cements. J Mater Sci Mater Med. 2017; 28(8):117. PMC: 5498620. DOI: 10.1007/s10856-017-5934-3. View

11.

Kucko N, de Lacerda Schickert S, Sobral Marques T, Herber R, van den Beuken J, Zuo Y . Tough and Osteocompatible Calcium Phosphate Cements Reinforced with Poly(vinyl alcohol) Fibers. ACS Biomater Sci Eng. 2021; 5(5):2491-2505. DOI: 10.1021/acsbiomaterials.9b00226. View

12.

Wu S, Lei L, Bao C, Liu J, Weir M, Ren K . An injectable and antibacterial calcium phosphate scaffold inhibiting Staphylococcus aureus and supporting stem cells for bone regeneration. Mater Sci Eng C Mater Biol Appl. 2021; 120:111688. DOI: 10.1016/j.msec.2020.111688. View

13.

Maity D, Mollick M, Mondal D, Bhowmick B, Bain M, Bankura K . Synthesis of methylcellulose-silver nanocomposite and investigation of mechanical and antimicrobial properties. Carbohydr Polym. 2012; 90(4):1818-25. DOI: 10.1016/j.carbpol.2012.07.082. View

14.

Qiu G, Huang M, Liu J, Wang P, Schneider A, Ren K . Antibacterial calcium phosphate cement with human periodontal ligament stem cell-microbeads to enhance bone regeneration and combat infection. J Tissue Eng Regen Med. 2021; 15(3):232-243. DOI: 10.1002/term.3169. View

15.

Pantak P, Czechowska J, Zima A . The influence of silane coupling agents on the properties of α-TCP-based ceramic bone substitutes for orthopaedic applications. RSC Adv. 2023; 13(48):34020-34031. PMC: 10663883. DOI: 10.1039/d3ra06027f. View

16.

Spadaro J, Webster D, Becker R . Silver polymethyl methacrylate antibacterial bone cement. Clin Orthop Relat Res. 1979; (143):266-70. View

17.

Kokubo T, Kim H, Kawashita M . Novel bioactive materials with different mechanical properties. Biomaterials. 2003; 24(13):2161-75. DOI: 10.1016/s0142-9612(03)00044-9. View

18.

Vezenkova A, Locs J . Sudoku of porous, injectable calcium phosphate cements - Path to osteoinductivity. Bioact Mater. 2022; 17:109-124. PMC: 8964990. DOI: 10.1016/j.bioactmat.2022.01.001. View

19.

Oh S, Lee G, Park J, Kim H . Osteoclastic cell behaviors affected by the α-tricalcium phosphate based bone cements. J Mater Sci Mater Med. 2010; 21(11):3019-27. DOI: 10.1007/s10856-010-4152-z. View

20.

Misch C, Qu Z, Bidez M . Mechanical properties of trabecular bone in the human mandible: implications for dental implant treatment planning and surgical placement. J Oral Maxillofac Surg. 1999; 57(6):700-6; discussion 706-8. DOI: 10.1016/s0278-2391(99)90437-8. View